Amber Edwards is Alastin Skincare’s new Chief Commercial Officer, effective July 31, 2020
Ms. Edwards most recently served as President of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan, Inc. where she was the Vice President of International Strategic Marketing, Medical Aesthetics Franchise, in the UK. She also has experience with Allergan in the US, in both aesthetic and therapeutic areas. Ms. Edwards began her career in Sales and Marketing roles at Pfizer.
"We are extremely pleased to have Amber Edwards join Alastin as a key member of the executive team to lead our US and International commercialization activities as we continue the rapid growth of our company," says Diane S. Goostree, President and CEO of Alastin Skincare, in a news release. "Amber's strategic perspectives and global experience will be extremely helpful as we leverage our innovative science and products and expand our footprint in the aesthetic marketplace."
Ms. Edwards adds, "I am thrilled to join an organization that has made such a notable mark in a crowded segment, and at a time they are experiencing tremendous opportunity and momentum. Alastin has demonstrated a commitment to science and ultimately to patients, identifying an innovative approach to helping physicians maximize patient results. I believe they have only scratched the surface and am honored to lead the commercial path forward."